Other metabolic proteins

The term 'Other metabolic proteins' is a heterogeneous classification used in pharmacological and biological databases to group proteins involved in metabolic pathways that do not fall into primary structural or functional families such as G protein-coupled receptors, kinases, or ion channels (ChEMBL, 2024). This category typically encompasses a wide variety of enzymes, transporters, and regulatory factors responsible for the synthesis, degradation, and transport of essential biomolecules, including lipids, carbohydrates, amino acids, and nucleotides (DrugBank, 2024). Because it is a catch-all designation rather than a specific molecular entity, it does not represent a single therapeutic target; instead, it serves as a repository for diverse molecules associated with a broad spectrum of conditions, from common metabolic syndromes like type 2 diabetes to rare inborn errors of metabolism (NIH, 2024). Consequently, there is no unified mechanism of action or safety profile for this group, as each protein within the category must be evaluated individually for its specific biological role and pharmacological relevance. This classification is primarily used for organizational purposes in drug discovery to manage targets that lack a more specific family designation.

Not applicable as this is a broad category of proteins rather than a specific molecular target.